Taken together, these data indicate that NAFLD is associated with downregulation of Siglec-7, Siglec-9, NKp30, and NKp46 and upregulation of CD57, PD-1, and ILT2 on CD56dim NK cells (Figure 3B). The gene discussed is NCR3; the disease is metabolic dysfunction-associated steatotic liver disease.